Navigation Links
January is Glaucoma Awareness Month
Date:1/19/2010

Summit Medical Group Offers Information on Glaucoma Risks, Screening and Treatment

Berkeley Heights, NJ (Vocus) January 19, 2010 -- During Glaucoma Awareness Month, Summit Medical Group wants to help people understand its risks, screening and treatment. Glaucoma is a degenerative disease of the eyes that causes vision loss. Because there often are no symptoms in its early stages, many people do not know they have it.

Risk
Glaucoma can affect people of all ages and races; however, certain people are at higher risk for it than others. For example, it is more common in people age 60 years or more. In addition, people of African and Hispanic descent have higher rates of glaucoma and associated blindness than those of other ethnic backgrounds. Researchers are unsure why the disease is more common in certain people, but they believe genetics has a role in who gets the disease. Level of care also is associated with its severity and how quickly it progresses.

Other risk factors for glaucoma include:

 
  • Diabetes mellitus
  • Elevated pressure in the eye(s)
  • Family history
  • High blood pressure
  • Injury to the eye(s)
  • Nearsightedness
  • Low central cornea thickness (less than .5 mm)
  • Obesity
  • Steroid use
Screening
“Detecting glaucoma early is critical for keeping the disease from getting worse," notes ophthalmologist Eric B. Gurwin, MD, of Summit Medical Group. “We recommend that people be screened every 1 to 2 years to ensure the health of their eyes. This frequency of
'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
3. January 1 Looms Large for Lymphoma Patients
4. China Shenghuo Pharmaceutical Holdings, Inc. to Launch 12Ways(R) Advertisement on CCTV in January 2008
5. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
6. The Long Term Care Insurance Explosion; January Conference to Celebrate Rapid Growth of LTC Protection and Light Fuse of Further Expansion
7. Datascope Adjourns Annual Meeting of Shareholders to January 3, 2008
8. NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
9. Biodel Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 7th, 2008
10. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
11. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... (PRWEB) July 14, 2014 The ... increasing demand for clean energy, initiatives of associations ... the major factors which drive the growth of ... metals are used in various direct applications ranging ... and x-rays, among others. , North America is ...
(Date:7/14/2014)... 14, 2014)In the 2,500+ years that have passed ... Chinese, it has been used to treat a ... nausea and vomiting, stroke rehabilitation, headaches, menstrual cramps, ... just a few. Now, a meta-analysis of ... month in Menopause , the journal of ...
(Date:7/14/2014)... There’s an old adage that says first ... Palette say the products offered in their preorder event ... can reserve The Lash Palette for $40,” said Jenelle Paris, ... , Paris explained that the first 1,000 have already been ... She went on to point out that her company is ...
(Date:7/14/2014)... The governments in many countries are developing health ... Solutions market. For instance, in the US, Barack Obama's ... Clinical Health Act under the American Recovery and Reinvestment ... Global Mobile Health Solutions market will grow at ... According to the report, one of the prime drivers ...
(Date:7/14/2014)... has entered into an agreement with one of ... novel drug candidates for the detection and treatment ... in novel antibody discovery and Roche,s expertise in ... the possibility of improved treatment for cancer, a ... collaboration makes use of BTI,s discovery of a ...
Breaking Medicine News(10 mins):Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 2Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 3Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 4Health News:Bothered by hot flashes? Acupuncture might be the answer 2Health News:The Lash Palette Preorder Event Has Officially Begun 2Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 2Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 3Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 4Health News:A*STAR partners Roche to develop new cancer therapeutics 2
... Aug. 7 /Xinhua-PRNewswire-FirstCall/ -- Aamaxan,Transport Group, Inc. ... AAXT),through its subsidiaries, including Shanghai Medical Technology ... a leading provider of Hemodialysis,equipment ("HDE") and ... diagnostic products, throughout Eastern China, today,announced the ...
... (Nasdaq:,MITI), a biopharmaceutical company focusing on the development ... inflammation and,autoimmune diseases, today announced its financial results ... 30, 2008., Summary of Recent Events:, ... update for the,BiTE(R) antibody blinatumomab (MT103/MEDI-538) at the ...
... - Annual revenue increases 5 percent to ... 76 percent to $3.64 and 11 percent to ... $23 billion, GAAP diluted, earnings per share from continuing operations increase 51 percent ... and 9 percent to $0.97 on a non-GAAP basis ...
... Calif., Aug. 7 The Board of Directors,of Endocare, ... 2008 an unsolicited,proposal from HealthTronics, Inc. (Nasdaq: HTRN ... common stock for $2.28 per share in cash., ... in consultation with its financial and legal advisors, will ...
... Consulting, a division of Gallagher Benefit Services, Inc., today announced the ... which examines current employee benefit trends and strategies. , ... ... division of Gallagher Benefit Services, Inc., today announced the release of ...
... Advice on Lap-Band Gastric Banding Procedure--Hundreds of Thousands with 30 ... Loss and to Ease Weight-Related Symptoms Including Diabetes, High Blood ... and Sleep Apnea. , ... Dallas ...
Cached Medicine News:Health News:Shanghai Medical Technology Co., Appoints Chief Financial Officer 2Health News:Shanghai Medical Technology Co., Appoints Chief Financial Officer 3Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 2Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 3Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 4Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 5Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 6Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 7Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 8Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 9Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 2Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 3Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 4Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 5Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 6Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 7Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 8Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 9Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 10Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 11Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 12Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 13Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 14Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 15Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 16Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 17Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 18Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 19Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 20Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 21Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 22Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 23Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 24Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 25Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 26
(Date:7/14/2014)... , 14 de julio de 2014 /PRNewswire-HISPANIC PR ... anunciar que Barry Epling , presidente de la ... CEO de la Compañía. El señor Epling es el ... que otorgó la licencia de su formulación, sus propiedades ... proveedor de apoyo financiero. "El señor ...
(Date:7/14/2014)... , July 14, 2014  Invivotek L.L.C., a ... pleased to announce that its animal research facility ... the Assessment and Accreditation of Laboratory Animal Care ... animals in science worldwide through voluntary accreditation and ... animal care and use in 38 countries. ...
(Date:7/14/2014)... July 14, 2014 Valeant Pharmaceuticals International, ... VRX) today announced it has filed a premerger ... 1976 (HSR) with the U.S. Federal Trade Commission ... Inc. (NYSE: AGN). About Valeant ... International, Inc. (NYSE/TSX: VRX) is a multinational specialty ...
Breaking Medicine Technology:BioAdaptives se prepara para el próximo paso 2BioAdaptives se prepara para el próximo paso 3Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5
... PCI program is critical, CHICAGO, March 29 ... and successfully in medical centers without,on-site cardiac surgical ... to quality. These are the findings of the,largest ... have on-site,cardiac surgery to PCI programs that transfer ...
... days and out to 450 days in patients who ... either bare metal or drug-eluting stents, CHICAGO, March 29 ... and highly,statistically significant reduction in the risk of coronary stent,thrombosis ... fatal consequences - in patients who received a stent as,compared ...
Cached Medicine Technology:Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 2Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 3Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 4Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 2Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 3Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 4Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 5Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 6Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 7
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: